The Bristol-Myers Squibb Children's Hospital at Robert Wood Johnson University Hospital

New Brunswick, New Jersey 08901

We've found

3 trials

at this facility

Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease

Status: Enrolling, Phase III
Updated: 12/31/1969

from

New Brunswick, NJ

Safety Of Rivipansel (GMI-1070) In The Treatment Of One or More Vaso-occlusive Crises In Hospitalized Subjects With Sickle Cell Disease

Status: Enrolling, Phase III
Updated: 12/31/1969

from

New Brunswick, NJ

Apixaban for the Acute Treatment of Venous Thromboembolism in Children

Status: Enrolling, Phase IV
Updated: 12/31/1969

from

New Brunswick, NJ

Use our guide to learn which trials are right for you!